Skip to main content
. 2022 Mar 31;14(4):761. doi: 10.3390/pharmaceutics14040761

Table 3.

Radiobiological parameters.

Samples α (alpha) β (beta) Area under Curve p-Values
(AUC)
F 10 p-Values
(F10)
T98G 0 0.2013 ± 0.0424 0 4.0182 ± 0.4933 NS 11.7694 ± 2.3651 NS
BPA 0.1926 ± 0.0346 0.0061 ± 0.0044 3.7831 ± 0.1943 # 9.3021 ± 0.4881 #
eBNPs 0.9589 ± 0.0271 0 1.0429 ± 0.0297 # 2.4025 ± 0.0686 ×
U251 0 0.1682 ± 0.0125 0.0018 ± 0.0031 4.3152 ± 0.3352 # 12.7821 ± 2.5917 ×
BPA 0.5083 ± 0.0072 0 1.9347 ± 0.0257 NS 4.5305 ± 0.0647 NS
eBNPs 0.7738 ± 0.2347 0 1.3679 ± 0.4105 # 3.1690 ± 0.9710 #
U87 0 0.2153 ± 0.0310 0.0002 ± 0.0003 3.8313 ± 0.3441 * 10.7210 ± 1.4673 ×
BPA 0.2626 ± 0.0268 0.0106 ± 0.0039 2.9948 ± 0.0881 # 6.8663 ± 0.0893 #
eBNPs 0.7501 ± 0.0874 0 1.3416 ± 0.1565 # 3.0982 ± 0.3674 ×

All values are presented as means ± standard deviations, except for p-values. The p-values ≤ 0.05 were considered indicative of statistical significance. NS—not significant (p > 0.05); *—p < 0.05; ×—p ≤ 0.01; #—p ≤ 0.001 (intergroup comparison by one-way ANOVA; 0 versus BPA, BPA versus eBNPs, and eBNPs versus 0).